 <h1>Navelbine Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>vinorelbine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about vinorelbine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Navelbine.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to vinorelbine: intravenous solution</i></p><h3>Warning</h3><p class="blackboxWarning-title">Intravenous route (Solution)</p><p>Myelosuppression: Severe myelosuppression resulting in serious infection, septic shock, hospitalization and death can occur. Decrease the dose or withhold vinorelbine in accord with recommended dose modifications.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, vinorelbine (the active ingredient contained in Navelbine) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking vinorelbine:</p><p>
<i>More common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bleeding gums</li>
<li>bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site</li>
<li>blood in the urine or stools</li>
<li>bluish color of the skin</li>
<li>burning, numbness, tingling, or painful sensations</li>
<li>changes in skin color</li>
<li>chest pain</li>
<li>chills</li>
<li>clay-colored stools</li>
<li>constipation</li>
<li>cough</li>
<li>dark urine</li>
<li>decreased appetite</li>
<li>dizziness</li>
<li>feeling of fullness in the ears</li>
<li>fever</li>
<li>headache</li>
<li>hoarseness</li>
<li>itching, skin rash</li>
<li>loss of appetite</li>
<li>loss of balance</li>
<li>loss of hearing</li>
<li>lower back or side pain</li>
<li>muscle pains, cramps, or stiffness</li>
<li>nausea</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>pinpoint red spots on the skin</li>
<li>ringing or buzzing in the ears</li>
<li>sneezing</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>stomach pain or tenderness</li>
<li>swelling of the feet or lower legs</li>
<li>swollen glands</li>
<li>tenderness, pain, swelling, warmth, skin discoloration, and prominent superficial veins over the affected area</li>
<li>trouble in hearing</li>
<li>troubled breathing with exertion</li>
<li>unsteadiness or awkwardness</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Chest tightness</li>
<li>increased sensitivity to pain or touch</li>
<li>overactive reflexes, followed by underactive reflexes</li>
<li>trouble breathing</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Agitation</li>
<li>chest discomfort</li>
<li>confusion</li>
<li>decreased awareness or responsiveness</li>
<li>decreased urine output</li>
<li>depression</li>
<li>frequent urination</li>
<li>hostility</li>
<li>irritability</li>
<li>loss of consciousness</li>
<li>lower abdominal cramping</li>
<li>muscle twitching</li>
<li>pain or discomfort in the arms, jaw, back, or neck</li>
<li>rapid weight gain</li>
<li>seizures</li>
<li>severe sleepiness</li>
<li>swelling of the face, ankles, or hands</li>
<li>unusual drowsiness, dullness, or feeling of sluggishness</li>
<li>vomiting</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Anxiety</li>
<li>blistering or sloughing of the skin</li>
<li>bloating</li>
<li>blurred vision</li>
<li>change in walking and balance</li>
<li>clumsiness or unsteadiness</li>
<li>coughing that sometimes produces a pink frothy sputum</li>
<li>difficult, fast, noisy breathing</li>
<li>difficulty in swallowing</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position </li>
<li>fainting</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>heartburn</li>
<li>hives or welts</li>
<li>increased sweating</li>
<li>increased thirst</li>
<li>indigestion</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>lightheadedness</li>
<li>nervousness</li>
<li>pain or burning in the throat</li>
<li>pain, redness, or swelling in the arm or leg</li>
<li>pains in the stomach, side, or abdomen, possibly radiating to the back</li>
<li>pale skin</li>
<li>pounding in the ears</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>redness, swelling, or pain of the skin</li>
<li>scaling of the skin on the hands and feet</li>
<li>slow heartbeat</li>
<li>ulceration of the skin</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking vinorelbine:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Chest pain</li>
<li>chills</li>
<li>confusion</li>
<li>fainting</li>
<li>fast heartbeat</li>
<li>fever</li>
<li>lightheadedness</li>
<li>lower back or side pain</li>
<li>painful or difficult urination</li>
<li>partial or slight paralysis</li>
<li>rapid, shallow breathing</li>
<li>severe constipation</li>
<li>severe stomach pain</li>
<li>severe vomiting</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>swollen glands</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of vinorelbine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Change in taste</li>
<li>diarrhea</li>
<li>difficulty in moving</li>
<li>impaired hearing</li>
<li>joint pain or swelling</li>
<li>lack or loss of strength</li>
<li>thinning or loss of hair</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Back pain</li>
<li>cracked, dry, scaly skin</li>
<li>feeling of warmth or heat</li>
<li>flushing or redness of the skin, especially on the face and neck</li>
<li>jaw pain</li>
<li>pain and redness of the skin at the place of earlier radiation treatment</li>
</ul><p>
<!-- end intravenous solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to vinorelbine: intravenous solution</i></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Neutropenia (89%), anemia (89%), leukopenia (88%), thrombocytopenia (29%)</p>
<p><b>Frequency not reported</b>: Febrile neutropenia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): AST increased (67%), bilirubin increased (13%)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (44%), constipation (35%), vomiting (20%), diarrhea (17%), stomatitis (15%), abdominal pain</p>
<p><b>Common</b> (1% to 10%): Esophagitis</p>
<p><b>Rare</b> (less than 0.1%): Paralytic ileus, pancreatitis </p>
<p><b>Frequency not reported</b>: GI bleeding<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site reactions (e.g., erythema, burning sensation, venous discoloration, local phlebitis)</p>
<p><b>Rare</b> (less than 0.1%): Local necrosis </p>
<p><b>Frequency not reported</b>: Neutropenic septicemia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Peripheral neuropathy (25%), neurological alterations (e.g., loss of deep tendon reflexes)</p>
<p><b>Uncommon</b> (0.1% to 1%): Severe paresthesia with sensory and motor symptoms<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (12%)</p>
<p><b>Rare</b> (less than 0.1%): Generalized skin reactions </p>
<p><b>Frequency not reported</b>: Erythema of hands and feet</p>
<p><b>Postmarketing reports</b>: Pruritus, urticaria<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Phlebitis, chest pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypotension, hypertension, flushing, peripheral coldness</p>
<p><b>Rare</b> (0.01% to 0.1%): Ischemic heart disease (e.g., angina pectoris, myocardial infarction), severe hypotension, cardiovascular collapse</p>
<p><b>Very rare</b> (less than 0.01%): Tachycardia, palpitations, altered heart rhythm</p>
<p><b>Frequency not reported</b>: Myocardial infarction<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dyspnea, cough</p>
<p><b>Uncommon</b> (0.1% to 1%): Bronchospasm</p>
<p><b>Rare</b> (less than 0.1%): Interstitial lung disease </p>
<p><b>Postmarketing reports</b>: Pneumonia, pulmonary edema<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Lower limb weakness</p>
<p><b>Common</b> (1% to 10%): Arthralgia, myalgia, pain in jaw</p>
<p><b>Rare</b> (less than 0.1%): Severe hyponatremia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Dysuria<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Stomatitis (15%), anorexia, weight loss</p>
<p><b>Common</b> (1% to 10%): Weight gain </p>
<p><b>Frequency not reported</b>: Anorexia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Systemic allergic reactions (e.g., anaphylaxis, anaphylactic shock, anaphylactoid reaction)</p>
<p><b>Postmarketing reports</b>: Angioedema<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Common (1% to 10%): Bacterial, viral, or fungal infections (e.g., respiratory tract, urinary tract, GI tract)</p>
<p><b>Uncommon</b> (0.1% to 1%): Severe sepsis, septicemia</p>
<p><b>Very rare</b> (less than 0.01%): Complicated septicemia (sometimes fatal)<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Visual disorder<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenia (36%), ototoxicity (10%)</p>
<p><b>Common</b> (1% to 10%): Fatigue, fever, pain at different sites (e.g., chest pain, pain at the site of the tumor, headache, dizziness, taste disorder</p>
<p><b>Uncommon</b> (0.1% to 1%): Ataxia<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Syndrome of inappropriate antidiuretic hormone secretion (SIADH)<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Navelbine (vinorelbine)." Glaxo Wellcome, Research Triangle Pk, NC. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Navelbine (vinorelbine)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: mitotic inhibitors</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Navelbine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Non-Small Cell Lung Cancer</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to vinorelbine: intravenous solution</i></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Neutropenia (89%), anemia (89%), leukopenia (88%), thrombocytopenia (29%)</p><p><b>Frequency not reported</b>: Febrile neutropenia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): AST increased (67%), bilirubin increased (13%)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (44%), constipation (35%), vomiting (20%), diarrhea (17%), stomatitis (15%), abdominal pain</p><p><b>Common</b> (1% to 10%): Esophagitis</p><p><b>Rare</b> (less than 0.1%): Paralytic ileus, pancreatitis </p><p><b>Frequency not reported</b>: GI bleeding<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site reactions (e.g., erythema, burning sensation, venous discoloration, local phlebitis)</p><p><b>Rare</b> (less than 0.1%): Local necrosis </p><p><b>Frequency not reported</b>: Neutropenic septicemia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Peripheral neuropathy (25%), neurological alterations (e.g., loss of deep tendon reflexes)</p><p><b>Uncommon</b> (0.1% to 1%): Severe paresthesia with sensory and motor symptoms<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (12%)</p><p><b>Rare</b> (less than 0.1%): Generalized skin reactions </p><p><b>Frequency not reported</b>: Erythema of hands and feet</p><p><b>Postmarketing reports</b>: Pruritus, urticaria<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Phlebitis, chest pain</p><p><b>Uncommon</b> (0.1% to 1%): Hypotension, hypertension, flushing, peripheral coldness</p><p><b>Rare</b> (0.01% to 0.1%): Ischemic heart disease (e.g., angina pectoris, myocardial infarction), severe hypotension, cardiovascular collapse</p><p><b>Very rare</b> (less than 0.01%): Tachycardia, palpitations, altered heart rhythm</p><p><b>Frequency not reported</b>: Myocardial infarction<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dyspnea, cough</p><p><b>Uncommon</b> (0.1% to 1%): Bronchospasm</p><p><b>Rare</b> (less than 0.1%): Interstitial lung disease </p><p><b>Postmarketing reports</b>: Pneumonia, pulmonary edema<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Lower limb weakness</p><p><b>Common</b> (1% to 10%): Arthralgia, myalgia, pain in jaw</p><p><b>Rare</b> (less than 0.1%): Severe hyponatremia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Dysuria<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Stomatitis (15%), anorexia, weight loss</p><p><b>Common</b> (1% to 10%): Weight gain </p><p><b>Frequency not reported</b>: Anorexia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Systemic allergic reactions (e.g., anaphylaxis, anaphylactic shock, anaphylactoid reaction)</p><p><b>Postmarketing reports</b>: Angioedema<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Common (1% to 10%): Bacterial, viral, or fungal infections (e.g., respiratory tract, urinary tract, GI tract)</p><p><b>Uncommon</b> (0.1% to 1%): Severe sepsis, septicemia</p><p><b>Very rare</b> (less than 0.01%): Complicated septicemia (sometimes fatal)<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Visual disorder<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenia (36%), ototoxicity (10%)</p><p><b>Common</b> (1% to 10%): Fatigue, fever, pain at different sites (e.g., chest pain, pain at the site of the tumor, headache, dizziness, taste disorder</p><p><b>Uncommon</b> (0.1% to 1%): Ataxia<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Syndrome of inappropriate antidiuretic hormone secretion (SIADH)<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Navelbine (vinorelbine)." Glaxo Wellcome, Research Triangle Pk, NC. </p><h2>More about Navelbine (vinorelbine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: mitotic inhibitors</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Navelbine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Non-Small Cell Lung Cancer</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>